FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA OKs Boston Scientific Taxus Stent for Small Vessels

[ Price : $8.95]

FDA approves Boston Scientifics Taxus Express2 Atom Paclitaxel-Eluting Coronary Stent System for use in treating small coronary ve...

MedWatch Info Sent to OMB

[ Price : $8.95]

Federal Register Notice: FDA sends a proposed collection of information on MedWatch to the Office of Management and Budget.

Finished Drug GMP Info Sent to OMB

[ Price : $8.95]

Federal Register Notice: FDA sends a proposed collection of information on CGMPs for finished pharmaceuticals to the Office of Man...

Dyax Files BLA for Hereditary Angioedema Therapy

[ Price : $8.95]

Dyax Corp. files a BLA for DX-88 (ecallantide), indicated for treating hereditary angioedema.

Takeda NDA for Alogliptin/Actos Combo

[ Price : $8.95]

Takeda submits an NDA for a combination tablet of SYR-322 (alogliptin) and Actos (pioglitazone HCl), indicated for treating Type 2...

Panel to Discuss Genzyme BLA

[ Price : $8.95]

Federal Register Notice: FDAs Endocrinologic and Metabolic Drugs Advisory Committee will meet 10/21 to discuss Genzyme Corp.s BLA ...

Lilly to Publish Physician Payments

[ Price : $8.95]

Lilly says it will start in 2009 publishing an online database of payments to physicians.

FDA Clears OBS Medical VitalAlert

[ Price : $8.95]

FDA clears an OBS Medical 510(k) for the Visensia VitalAlert, an automated early warning system that monitors a patients five vita...

AZ Cefotan Supplies Depleted

[ Price : $8.95]

FDA updates drug Cefotan and Mitozytrex discontinuation information.

Scientific Value Trumps Marketing Intent

[ Price : $8.95]

American Enterprise Institute scholar John Calfee says its OK if clinical trials are conducted for marketing purposes if they yiel...